 |
|
|
|
|
|
|
| Company / Phase I Clinical Unit
The clinic
Acclaim Pharma Research Inc. offers a state-of-the-art Phase I clinical facility where early clinical trials are conducted. There are two spacious and self-contained clinics housed within the 10,600 square foot facility with a total capacity of 90 beds. Our facility design includes a separate male/female sleeping area. Acclaim Pharma employs full time professionals including physicians, study coordinators, nurses, and other allied health professionals with extensive expertise in a number of therapeutic areas to meet our client's need. Acclaim Pharma clinics operate under Good Clinical Practice Guidelines. The services provided by Acclaim Pharma clinic include:
- First In Human
- Bioequivalence
- Bioavailability
- Pharmacokentics
- Pharmacodynamic
- Drug/drug Interaction
- Drug Metabolism
Our Advantages
- Expertise in conducting clinical trials under Good Clinical Practice (GCP) guidelines
- Expertise in management of bioequivalence studies with wide range of pharmaceutical formulations
- Knowledge in the regulatory requirements for bioequivalence studies and clinical trials
- Large pool of healthy non-smoking subjects
- Large pediatric and geriatric population
- On site phlebotomy with expertise in processing and shipping plasma samples to GLP bioanalytical laboratories
- Across from University of Western Ontario with approximately 29,000 students and staff
- Central location in London with free parking, and easy access from Highways 401, 402, as well as the London Airport
- In-house protocol development by expert pharmacokinetics
- Regulatory submission of the projects to Health Canada and Independent Ethics Board
Client Services
Acclaim Pharma Client Services staff are experienced in managing each project from initial concept to the final report. Once contacted by the client a study design and quotation will be forwarded and tentative clinic dates will be scheduled, and routine requirements will be put in place to have your study completed as expeditiously as possible. Client Services update the client on the progress of the project on a routine basis.For prospective sponsors, if you are interested in placing your next Phase I trial or Bioequivalence study at Acclaim Pharma Research, or if you would like to first visit our site in London, Ontario please contact Dr. A. Gupta at (519) 657-4222 Ext. 277. |
| |
|
| |
|
|
|
|
|
| |
|
| | |
